rs121908843

Variant summary

Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate

The NM_003722.5(TP63):​c.1681T>G​(p.Cys561Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C561R) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)

Consequence

TP63
NM_003722.5 missense

Scores

9
8
2

Clinical Significance

Likely pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 7.67
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 13 ACMG points.

PM1
In a domain SAM (size 66) in uniprot entity P63_HUMAN there are 9 pathogenic changes around while only 1 benign (90%) in NM_003722.5
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-189890817-T-C is described in Lovd as [Likely_pathogenic].
PP2
Missense variant in the TP63 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 73 curated pathogenic missense variants (we use a threshold of 10). The gene has 15 curated benign missense variants. Gene score misZ: 2.2077 (below the threshold of 3.09). Trascript score misZ: 3.5096 (above the threshold of 3.09). GenCC associations: The gene is linked to Rapp-Hodgkin syndrome, ADULT syndrome, split hand-foot malformation 4, limb-mammary syndrome, premature ovarian failure 21, split hand-foot malformation, ankyloblepharon-ectodermal defects-cleft lip/palate syndrome, EEC syndrome, ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.98
PP5
Variant 3-189890817-T-G is Pathogenic according to our data. Variant chr3-189890817-T-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 6536.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-189890817-T-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TP63NM_003722.5 linkc.1681T>G p.Cys561Gly missense_variant Exon 13 of 14 ENST00000264731.8 NP_003713.3 Q9H3D4-1A0A0S2Z4N5
TP63NM_001114980.2 linkc.1399T>G p.Cys467Gly missense_variant Exon 11 of 12 ENST00000354600.10 NP_001108452.1 Q9H3D4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP63ENST00000264731.8 linkc.1681T>G p.Cys561Gly missense_variant Exon 13 of 14 1 NM_003722.5 ENSP00000264731.3 Q9H3D4-1
TP63ENST00000354600.10 linkc.1399T>G p.Cys467Gly missense_variant Exon 11 of 12 1 NM_001114980.2 ENSP00000346614.5 Q9H3D4-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome Pathogenic:1
Feb 01, 2001
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

TP63-Related Spectrum Disorders Pathogenic:1
Jan 25, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Cys561 amino acid residue in TP63. Other variant(s) that disrupt this residue have been observed in individuals with TP63-related conditions (PMID:11159940, 19793345), which suggests that this may be a clinically significant amino acid residue. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been reported to affect TP63 protein function (PMID:21615690). This variant has been observed in an individual affected with ankyloblepharon-ectodermal dysplasia-clefting syndrome (PMID: 11159940). This variant is also known as c.1546T>G, p.Cys526Gly in the literature. ClinVar contains an entry for this variant (Variation ID: 6536). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with glycine at codon 561 of the TP63 protein (p.Cys561Gly). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and glycine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.82
D;.;.;.;.
Eigen
Pathogenic
0.69
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;D;D;D;D
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.98
D;D;D;D;D
MetaSVM
Uncertain
0.38
D
MutationAssessor
Uncertain
2.1
M;.;.;.;.
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-3.8
D;D;D;D;D
REVEL
Pathogenic
0.88
Sift
Benign
0.061
T;T;T;D;T
Sift4G
Uncertain
0.0030
D;D;D;D;D
Polyphen
1.0
D;.;D;D;.
Vest4
0.97
MutPred
0.92
Loss of helix (P = 0.0104);.;.;.;.;
MVP
0.98
MPC
1.7
ClinPred
0.98
D
GERP RS
5.7
Varity_R
0.83
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121908843; hg19: chr3-189608606; API